Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America (Q33853922)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America (English)

1 reference

Europe PubMed Central

29 July 2017

anti-retroviral agent

0 references

Margot B Kushel

object named as

Margot B Kushel

26

0 references

Benigno Rodriguez

object named as

Benigno Rodriguez

17

0 references

object named as

Stephen J Gange

2

0 references

Michael John Gill

object named as

M John Gill

10

0 references

object named as

Robert S Hogg

6

0 references

1

object named as

Steven G Deeks

1 reference

Europe PubMed Central

29 July 2017

Sonia Napravnik

20

object named as

Sonia Napravnik

1 reference

Europe PubMed Central

29 July 2017

7

object named as

Joseph J Eron

1 reference

Europe PubMed Central

29 July 2017

8

object named as

John T Brooks

1 reference

Europe PubMed Central

29 July 2017

19

object named as

Gregory D Kirk

1 reference

Europe PubMed Central

29 July 2017

Mari M Kitahata

3

object named as

Mari M Kitahata

1 reference

Europe PubMed Central

29 July 2017

4

object named as

Michael S Saag

1 reference

Europe PubMed Central

29 July 2017

James J Goedert

27

object named as

James J Goedert

1 reference

Europe PubMed Central

29 July 2017

5

object named as

Amy C Justice

1 reference

Europe PubMed Central

29 July 2017

Michael A Horberg

23

object named as

Michael A Horberg

1 reference

Europe PubMed Central

29 July 2017

Michael J Silverberg

24

object named as

Michael J Silverberg

1 reference

Europe PubMed Central

29 July 2017

9

object named as

Sean B Rourke

1 reference

Europe PubMed Central

29 July 2017

21

object named as

Anita R Rachlis

1 reference

Europe PubMed Central

29 July 2017

Timothy R. Sterling

18

object named as

Timothy R Sterling

1 reference

Europe PubMed Central

29 July 2017

15

object named as

Marina B Klein

1 reference

Europe PubMed Central

29 July 2017

Lisa A. Jacobson

16

object named as

Lisa P Jacobson

1 reference

Europe PubMed Central

29 July 2017

Liviana Calzavara

22

object named as

Liviana M Calzavara

1 reference

Europe PubMed Central

29 July 2017

Constance A. Benson

12

object named as

Constance A Benson

1 reference

Europe PubMed Central

29 July 2017

Rosemary G McKaig

28

object named as

Rosemary G McKaig

1 reference

Europe PubMed Central

29 July 2017

25

object named as

Kelly A Gebo

1 reference

Europe PubMed Central

29 July 2017

13

object named as

Ann C Collier

1 reference

Europe PubMed Central

29 July 2017

author name string

Ronald J Bosch

11

1 reference

Europe PubMed Central

29 July 2017

Jeffrey N Martin

14

1 reference

Europe PubMed Central

29 July 2017

Richard D Moore

29

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

29 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

29 July 2017

49

1 reference

Europe PubMed Central

29 July 2017

10

1 reference

Europe PubMed Central

29 July 2017

1582-1590

1 reference

Europe PubMed Central

29 July 2017

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Maraviroc for previously treated patients with R5 HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Raltegravir with optimized background therapy for resistant HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

What is the risk of mortality following diagnosis of multidrug-resistant HIV-1?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Treatment of antiretroviral-drug-resistant HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

5 July 2018

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2871149

29 October 2018

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV integrase inhibitors--out of the pipeline and into the clinic

1 reference

https://pubmed.ncbi.nlm.nih.gov/19845473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33853922&oldid=1945933867"